Strong Industry Presence Adelphi Real World operates in the expanding field of real world evidence generation within healthcare, offering tailored insights for pharmaceutical companies, medical affairs, and health outcomes teams. This positions them as a key partner for firms seeking to demonstrate product value and achieve market access across multiple regions.

Global Data Capabilities With extensive experience conducting studies across Europe, USA, Asia, and Latin America, Adelphi offers multinational and domestic evidence, making their services attractive to global pharmaceutical and healthcare organizations aiming to support products in diverse markets.

Advanced Tech Stack Leveraging data visualization and analysis tools such as Power BI and Microsoft Teams, Adelphi is well-equipped to deliver sophisticated, real-time insights. This technological proficiency can be marketed to potential clients looking for innovative data solutions to enhance decision-making.

Reputable Market Position Operating with a revenue estimate between 25 and 50 million dollars and over 200 employees, Adelphi stands out as a mid-sized, established player in the health evidence space, offering opportunities for strategic partnerships with large pharmaceutical firms and healthcare consultancies.

Complementary Service Offerings Adelphi’s focus on Disease Specific Programmes and non-interventional studies aligns well with the needs of companies seeking real-world evidence for regulatory approval, market access, and post-marketing surveillance, creating cross-selling opportunities across their product lifecycle services.